After a Rare Diagnosis, This Man Found Strength in Fitness. Now, His Story Is Inspiring Others
While training wasn't exactly instinctive, Monaco quickly found that by strengthening his body, he could at least begin to ...
MyChesCo on MSN16h
Larimar Therapeutics Advances Nomlabofusp Program Amid Regulatory Support
Larimar Therapeutics, Inc. (Nasdaq: LRMR) has announced significant progress in its nomlabofusp program for Friedreich’s ...
Independent.ie on MSN2d
See photos as Wicklow concert raises significant funds for Friedreich’s Ataxia research
Dunlavin was alive with the sounds of music and song when the community came together at St Nicholas Church of Ireland for a ...
Action News Now1d
Wellness Wednesday: NorCal man with rare disease cycles for a cure & how you can help
Kyle Bryant was diagnosed with Friedreich's Ataxia, or FA, at 17 years old. Friedreich's Ataxia is a a rare neuromuscular disease that affects 1 in 50,000 people. Over the last ...
The Sun Times News12d
Chelsea Hosts Families for Friedreich’s Ataxia Foundation Fundraiser
The Families for Friedreich’s Ataxia Foundation is grateful for the incredible support from Chelsea and the surrounding ...
Healio7d
VIDEO: Awareness of Friedreich’s ataxia may increase tertiary care center referrals
In addition, I think the recognition across all diseases where not everyone is going to be an expert in FA, and people can refer readily to tertiary care centers and even ordinary care centers that ...
Larimar Therapeutics should be bought on weakness, says Citi
Citi says a share overhang has been removed after Larimar Therapeutics (LRMR) announced it has received FDA alignment on an accelerated ...
American Association of Individual Investors4d
Why Larimar Therapeutics, Inc.’s (LRMR) Stock Is Down 10.24%
Larimar Therapeutics, Inc.’s LRMR share price has dipped by 10.24%, which has investors questioning if this is right time to ...